Search

Search Results

• 

  04 | Association of a novel TERT polymorphism with poorer survival in male patients with melanoma Fortunato Cassalia¹, Maria Santa Rocca², Andrea Di Nisio³, Paolo del Fiore*⁴, Clara Benna^5|7, Ilaria Cosci⁶, Simone Mocellin^4|5, Alberto Ferlin*^2|6 | ¹Department of Dermatology, University of Padua, Padua; ²Unit of Andrology and Reproductive Medicine, University Hospital of Padua, Padua; ³Department of Wellbeing, Nutrition and Sport, Pegaso Telematic University, Naples; ⁴Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; ⁵Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; ⁶Department of Medicine, University of Padua, Padua; ⁷Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10746

  325
• 

  20 | How Covid-19 pandemic influenced the diagnosis of new primary melanoma: a retrospective, multicenter study by the Italian Society of Oncological Surgery Giuseppe Sciacca*^1|2, Luca Nespoli¹, Virginia Caliendo², Dario Piazzalunga³, Piero Rossi⁴, Marco Clementi⁵, Corrado Caracò⁶, Salvatore Asero⁷, Matteo Mascherini⁸, Franco De Cian⁸, Francesco Russano⁹, Paolo Del Fiore⁹, Sara Coppola¹⁰, Elisabetta Pennacchioli¹⁰, Pietro Gallina¹¹, Marzia Franzò¹², Marco Rastrelli^9|12 | ¹General and Emergency Surgery, School of Medicine and Surgery, Milano-Bicocca University, Fondazione IRCCS San Gerardo dei Tintori, Monza; ²Department of Surgery, Dermatologic Surgery Section, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin; ³Unit of Surgery, Papa Giovanni XXIII Hospital, Bergamo; ⁴Dipartimento Di Scienze Chirurgiche, Università di Roma Tor Vergata, Policlinico Tor Vergata, Rome; ⁵General Surgical Unit, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila; ⁶Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori "Fondazione Pascale" IRCCS, Napoli; ⁷Soft Tissue U.O. Surgical Oncology-Soft Tissue Tumors, Dipartimento di Oncologia, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi di Catania; ⁸Department of Surgical Sciences and Integrated Diagnostic DISC, University of Genoa; ⁹Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova; ¹⁰Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milano; ¹¹Directorate General, Veneto Institute of Oncology IOV-IRCCS, Padua; ¹²Department of Surgery, Oncology and Gastroenterology, DISCOG, University of Padua, AOPD Azienda Ospedale Università Padova, Padova, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10762

  312
• 

  29 | The extracellular vesicle potential for the early detection of resistance to immunotherapy in melanoma patients Cristina Catoni¹, Cristina Poggiana¹, Alessandro Francesco Piazza¹, Jacopo Pigozzo², Luisa Piccin², Chiara Menin¹, Stefania Pellegrini¹, Valentina Salizzato², Paolo Del Fiore⁴, Simone Mocellin^3|4, Vanna Chiarion-Sileni², Valentina Guarneri^2|3, Antonio Rosato^1|3, Maria Chiara Scaini¹ | ¹Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; ²Medical Oncology 2, Veneto Institute of Oncology, IOV-IRCCS, Padua; ³Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; ⁴Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10771

  266
• 

  31 | Effectiveness and safety of adjuvant combo-targeted and immunotherapy in melanoma patients Valentina Salizzato¹, Luisa Piccin¹, Alessio Fabozzi², Paolo Del Fiore³, Francesco Cavallin⁴, Chiara Cacco^1|5, Simone Mocellin^3|5, Marcodomenico Mazza³, Valentina Guarneri^1|5, Jacopo Pigozzo¹ | ¹Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova; ²Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padova; ³Soft-Tissue, Peritoneum and Melanoma Surgical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova; ⁴Independent Statistician, Solagna; ⁵Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10773

  246
• 

  21 | Melanoma in situ: long-term outcomes and follow-up strategies based on risk stratification Beatrice De Checchi¹, Paolo del Fiore², Irene Russo², Chiara Trevisiol², Marco Domenico Mazza², Saveria Tropea², Francesco Russano², Mauro Alaibac³, Carlomaria Gianesini⁴, Giovanni Madeo⁴, Simone Mocellin^2|4 | ¹Department of Medicine, University of Padua, Padua; ²Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; ³Department of Dermatology, University of Padua; ⁴Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10763

  291